Forget Moderna -- This Is A More Lucrative Coronavirus Stock

Adria Cimino, The Motley Fool
·4-min read
Forget Moderna -- This Is A More Lucrative Coronavirus Stock
Forget Moderna -- This Is A More Lucrative Coronavirus Stock

Moderna (NASDAQ: MRNA) is without a doubt one of the most talked about coronavirus stocks these days. The company was the first to launch its coronavirus vaccine candidate in human trials and is still a leader in the race to the finish line. Sure, Abbott is only up around 25% this year.